NNMT and obesity due to melanocortin 4 receptor deficiency: Nicotinamide N-methyltransferase, which catalyzes methylation of niacinamide to generate 1-methylnicotinamide, has been proposed as a promising therapeutic target to prevent or treat obesity and diabetes [82,83].